Yasuhiko Iwamoto

发表论文 382 篇 · 总被引 16202 次 · h-index 60

代表论文

• Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study (2014 · Cardiovascular Diabetology · 被引 222)
• Insulin degludec compared with insulin glargine in insulin‐naïve patients with type 2 diabetes: A 26‐week, randomized, controlled, P an‐ A sian, treat‐to‐target trial (2013 · Journal of Diabetes Investigation · 被引 103)
• Long-term safety and efficacy of tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, as monotherapy or in combination with other oral antidiabetic agents in Japanese patients with type 2 diabetes mellitus: multicenter, open-label, randomized controlled trials (2014 · Expert Opinion on Pharmacotherapy · 被引 80)
• Skin Autofluorescence Reflects Integration of Past Long-Term Glycemic Control in Patients With Type 1 Diabetes (2013 · Diabetes Care · 被引 61)
• Predictive ability of visit-to-visit variability in HbA1c and systolic blood pressure for the development of microalbuminuria and retinopathy in people with type 2 diabetes (2017 · Diabetes Research and Clinical Practice · 被引 49)
• Differences in physician and patient perceptions about insulin therapy for management of type 2 diabetes: the DAWN Japan study (2013 · Current Medical Research and Opinion · 被引 49)